ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43421
0.00%
Bitcoin
96,718.61
-0.50%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. abrdn Life Sciences Investors (HQL) Share Price

abrdn Life Sciences Investors

abrdn Life Sciences Investors (HQL)

NYSE
13.50
0.35
(2.66%)
Closed December 21 3:00PM
Delayed by 15 minutes
13.49
-0.01
(-0.07%)
After Hours: 6:59PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
13.50
Bid
-
Ask
-
Volume
94,492
13.16 Day's Range 13.54
12.76 52 Week Range 15.8999
Market Cap
346.675M
Previous Close
13.15
Open
13.17
Last Trade
901
@
13.5
Last Trade Time
Financial Volume
US$ 1,266,420
VWAP
13.4024
Average Volume (3m)
79,867
Shares Outstanding
25,679,636
Dividend Yield
14.52%
PE Ratio
15.50
Earnings Per Share (EPS)
0.87
Revenue
3.5M
Net Profit
22.35M

About abrdn Life Sciences Investors

Tekla Life Sciences Investors is a United States based closedend management investment company. Its investment objective is to seek longterm capital appreciation by investing primarily in the securities of life sciences companies. Tekla Life Sciences Investors is a United States based closedend management investment company. Its investment objective is to seek longterm capital appreciation by investing primarily in the securities of life sciences companies.

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Website
www.teklacap.com/hql.html
Headquarters
Boston, Massachusetts, USA
Founded
-
abrdn Life Sciences Investors is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker HQL. The last closing price for abrdn Life Sciences Inve... was US$13.15. Over the last year, abrdn Life Sciences Inve... shares have traded in a share price range of US$ 12.76 to US$ 15.8999.

abrdn Life Sciences Inve... currently has 25,679,636 shares outstanding. The market capitalization of abrdn Life Sciences Inve... is US$337.69 million. abrdn Life Sciences Inve... has a price to earnings ratio (PE ratio) of 15.50.

Ask ADVFN Intelligence (AI)

HQL Latest News

More News

Form 3 - Initial statement of beneficial ownership of securities

December 20 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

December 20 2024
Edgar (US Regulatory)

Form N-CEN - Annual Report for Registered Investment Companies

December 16 2024
Edgar (US Regulatory)

Form N-CSR - Certified Shareholder Report

December 09 2024
Edgar (US Regulatory)

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

November 27 2024
Edgar (US Regulatory)

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

August 28 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 27 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

July 18 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.43-3.0868628858613.9313.9613.1115100813.47319473CS
4-0.33-2.3861171366613.8314.468613.119611713.84880323CS
12-1.53-10.179640718615.0315.3713.117986714.39973289CS
26-0.2-1.459854014613.715.899913.118641414.79321112CS
520.241.8099547511313.2615.899912.769342114.19167683CS
156-5.81-30.088037286419.3119.8911.349190314.31070384CS
260-4.07-23.164484917517.5722.711.349022715.9537892CS

HQL - Frequently Asked Questions (FAQ)

What is the current abrdn Life Sciences Inve... share price?
The current share price of abrdn Life Sciences Inve... is US$ 13.50
How many abrdn Life Sciences Inve... shares are in issue?
abrdn Life Sciences Inve... has 25,679,636 shares in issue
What is the market cap of abrdn Life Sciences Inve...?
The market capitalisation of abrdn Life Sciences Inve... is USD 337.69M
What is the 1 year trading range for abrdn Life Sciences Inve... share price?
abrdn Life Sciences Inve... has traded in the range of US$ 12.76 to US$ 15.8999 during the past year
What is the PE ratio of abrdn Life Sciences Inve...?
The price to earnings ratio of abrdn Life Sciences Inve... is 15.5
What is the cash to sales ratio of abrdn Life Sciences Inve...?
The cash to sales ratio of abrdn Life Sciences Inve... is 99.05
What is the reporting currency for abrdn Life Sciences Inve...?
abrdn Life Sciences Inve... reports financial results in USD
What is the latest annual turnover for abrdn Life Sciences Inve...?
The latest annual turnover of abrdn Life Sciences Inve... is USD 3.5M
What is the latest annual profit for abrdn Life Sciences Inve...?
The latest annual profit of abrdn Life Sciences Inve... is USD 22.35M
What is the registered address of abrdn Life Sciences Inve...?
The registered address for abrdn Life Sciences Inve... is 100 FEDERAL STREET, 19TH FLOOR, BOSTON, MASSACHUSETTS, 02110
What is the abrdn Life Sciences Inve... website address?
The website address for abrdn Life Sciences Inve... is www.teklacap.com/hql.html
Which industry sector does abrdn Life Sciences Inve... operate in?
abrdn Life Sciences Inve... operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VNCEVince Holding Corp
US$ 4.70
(69.06%)
1.06M
SRFMSurf Air Mobility Inc
US$ 3.33
(23.79%)
367.21k
BBBlackBerry Limited
US$ 3.685
(23.66%)
40.27M
ALURAllurion Technologies Inc
US$ 0.3439
(22.87%)
702.83k
CLWClearWater Paper Corporation
US$ 30.26
(22.46%)
3.5M
IIPRInnovative Industrial Properties Inc
US$ 73.50
(-22.91%)
3.15M
KUKEKuke Music Holding Limited
US$ 0.31
(-20.51%)
61.48k
NVONovo Nordisk
US$ 85.00
(-17.83%)
53.81M
CANGCango Inc
US$ 5.08
(-11.81%)
2.44M
BNEDBarnes and Noble Education Inc
US$ 9.965
(-10.31%)
1.55M
QBTSD Wave Quantum Inc
US$ 6.638
(4.21%)
124.23M
PFEPfizer Inc
US$ 26.36
(2.29%)
111.08M
APOApollo Global Management Inc
US$ 171.03
(0.83%)
94.47M
TAT&T Inc
US$ 22.75
(0.80%)
88.77M
FFord Motor Company
US$ 9.885
(1.49%)
87.61M

Discussion

View Full Feed
Fdc4 Fdc4 4 minutes ago
Bashers are necessary, specially to Bulls when they fall in love with a ticker that can’t even see beyond their nose any defects, if any. I have always said it, when it comes to bashers and bulls: Bashers got evidence and follow logic, bulls are more about the luck and hope many times in OTCM. Both
OTCM
Smartypants2 Smartypants2 5 minutes ago
Ignoring the obvious progress being made with NEXBOARD will only make you look like a bigger fool in the end...and that's saying something.
XERI
Hoskuld Hoskuld 6 minutes ago
Karuna was purchased after P3 results were out.

Expectations are tempered because Anavex has the goods but has essentially sabotaged itself over and over with underpowered, poorly designed trials. They are literally doing it again with 3-71. Once they execute and show they have le
AVXL
OMOLIVES OMOLIVES 7 minutes ago
You mean Bill Clinton. At least by that political chart. You should look at that again.
TurboMinotaur94 TurboMinotaur94 8 minutes ago
keep an eye on ILIKA they are sending their GOLLITH EV "Solid State" Battery to OEM's for testing. A new EV battery showing much promise. Currently their share price is $0.26 a share "ya gotta be kiddin"!!
ILIKF
johnydollar johnydollar 8 minutes ago
What are you shorts waiting for.......

Bankruptcy......

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹
DBMM
sam1933 sam1933 10 minutes ago
✅️The list of Hedera’s achievements is growing, with analysts predicting the HBAR price rally to $3 by 2025, reported CNF.
The team announced on X that its Asset Tokenization Studio has been nominated for
the INATBA Awards 2025 in the “Most Exciting Tokenization Solution” category.
HBARUSD
sortagreen sortagreen 11 minutes ago
Saturday’s Poetic Polemic…
Mark Lysgaard

The Battle at Bended Knee
12/21/24

Many complained about the Trump train,
And the election is hard to believe,
And now his once critics retreat to Key West,
They’re getting down on Bended Knee.
againstallodds againstallodds 11 minutes ago
Show the link that proves that!!

GNCP is a stinky toxic share selling scam
GNCP
Hosai Hosai 11 minutes ago
"Karuna, of course, was bought out by BMY for 14b before their Ph3 was complete."

I agree with your post overall but in terms of Karuna it was bought out for this after posting results for their 2 small phase 3s and was bought out 3 months after they submitted their NDA to FDA but yes
BMY
DonVance DonVance 11 minutes ago
Almost one hundred billion in volume today. Unreal.
SHIBUSD
Ribo Ribo 13 minutes ago
Quarterly Report
https://www.otcmarkets.com/otcapi/company/financial-report/419406/content
RMRK
band aid band aid 13 minutes ago
Merry Christmas Newbies, stay clear of this if your trying to make money.
BIEL
Jetmek_03052 Jetmek_03052 14 minutes ago
There isn’t even a single “naked short” share that has to be covered.

All you longs have been waiting for a squeeze that will never happen!

It’s all a giant fantasy.
DBMM
Elroy Jetson Elroy Jetson 14 minutes ago
This works on FIrefox and MS Edge, but works less universally on Chrome https://adblockplus.org/

Google wants to make a living on ads
StayHumble StayHumble 14 minutes ago
wow💹344M+ BUYS💹Lots of Xperts Here!💹 https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/trades
HMBL
1vman 1vman 15 minutes ago
*****🚽HCWC🚽 Hilarious !!! There's no Walmart BUYOUT for this stock Yup facts Matter - no where below in da link does it state this

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMicroOct2022.pdf
HCWC
Samuel J Samuel J 15 minutes ago
Divide and Conquer!

That's the motto nowadays sadly speaking. 

And people actually buy into this sh!t.
AZRH
awesomed007 awesomed007 15 minutes ago
When is Q4 reporting? February? I can’t wait$!
SPZI
xodcode xodcode 16 minutes ago
Conservatively $40 to $50 per share within 3 months of EMA approval!

WGT!
AVXL
tedpeele tedpeele 17 minutes ago
Newbies: Here's my 'counter-Proto' rebuttals and all kinds of DD to help you out.

Funny how Proto - the daily cut and paste man - now has adopted my use of the word "DESTROY". Just makes me chuckle. All you really need to know is he has been claiming "deal any day" ever since arriving
LWLG
georgejjl georgejjl 17 minutes ago
I guess that Anavex could have sales of $14 billion during the first full year after approval in 2026 by the EMA in the EU alone based on capturing a 25% market share of the 8 million people in the EU with Alzheimer’s disease at a prescription cost of $7,000 per year per patient.

Good
AVXL
Risk vs Reward Risk vs Reward 18 minutes ago
Excellent interview, of course he has to be grounded on the rev potential from different companies. As it is on them to adopt KULR’s tech. KULR is everywhere and about to be in everything from drones to nuke plants…….

This is the stock play of 2025 !
KULR
Samuel J Samuel J 18 minutes ago
I am not even an American but it pains me to see the leader economically speaking globally fall apart to these politicians and business leaders who ruined what America is and slowly depleted its hegemony around the world. All because of greed and not trusting the economic foundation of America and t
AZRH

Your Recent History

NYSE
HQL
abrdn Life Sciences Inve...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads